baber/WOPTO huggingface dataset:
Patent AU-1276399-A (AU)
Title: Neuronal uses of bmp-11
Inventor: CELESTE ANTHONY J
IPC: C12N15/00
Filed: 1998-10-23
Abstract: Purified BMP-11 proteins and processes for producing them are disclosed. Recombinant DNA molecules encoding the BMP-11 proteins are also disclosed. The proteins may be useful in regulating follicle stimulating hormone, such as for contraception. In addition, the proteins may be useful for the induction and/or maintenance of bone, cartilage and/or other connective tissue, and/or neuronal tissue.
Patent AU-1543297-A (AU)
Title: Milk-based pasty food products
Inventor: PAHNKE OTTO
IPC: A23P20/20
Filed: 1997-01-20
Abstract: Pasty milk-based food products are disclosed with a high energy content per unit of consumption. The food product essentially consits of milk with 15 wt.% fat, 5-20 wt.% sugar and a thickening system with 1.5-2.5 wt.% starch and 0.1-0.5 % gelling agents which give the food product a pasty structure with a viscosity of at least 3 Pa.s at 10  DEG C. The starch/gelling agent ratio equals 15:1 to 5:1 by weight. Cocoa powder, fruit pulp and aromas can be added to this pasty food product with a high solids content. Preferably, these pasty food products are formed as a multilayer arrangement with different colours and flavours.
Patent AU-1707995-A (AU)
Title: Multilingual operation and maintenance interface for a telecommunication exchange
Inventor: VESTERINEN TIMO
IPC: G06F40/40
Filed: 1995-02-14
Abstract: PCT No. PCT/FI95/00065 Sec. 371 Date Aug. 7, 1996 Sec. 102(e) Date Aug. 7, 1996 PCT Filed Feb. 14, 1995 PCT Pub. No. WO95/21529 PCT Pub. Date Aug. 17, 1995A multilingual operation and maintenance interface for a telecommunication exchange. The interface includes a plurality of modules and a plurality of resource files. Alphanumeric information in a different target language and related to interactive communication with the interface is included in a resource file. At least one resource file is an intermediate language file including intermediate language information other than alphanumeric information in a target language. An external device is provided to display a control response of the operation and maintenance interface in the target language.
Patent AU-1904400-A (AU)
Title: Aluminum free-cutting alloy, processes for the production thereo f and use thereof
Inventor: SMOLEJ ANTON
IPC: C22C21/16
Filed: 1999-12-20
Abstract: A free-cutting aluminum alloy without lead as an alloy element, containing: (a) as alloy elements: 0.5 to 1.0 wt. % Mn; 0.4 to 1.8 wt. % Mg; 3.3 to 4.6 wt. % Cu; 0.4 to 1.9 wt. % Sn; 0 to 0.1 wt. % Cr; 0 to 0.2 wt. % Ti; (b) as impurities: up to 0.8 wt. % Si; up to 0.7 wt. % Fe; up to 0.8 wt. % Zn; up to 0.1 wt. % Pb; up to 0.1 wt. % Bi; up to 0.3 wt. % total of other impurities; and (c) the balance being substantially aluminum. The process includes the steps of semicontinuously casting the above alloy composition followed by homogenization annealing, cooling, heating to a working temperature for extrusion, extruding at a maximum temperature of 380° C., followed by press-quenching and aging. The aging may be a natural aging or an artificial aging. A cold working step and/or a tension straightening step also may be conducted after the press-quenching step. The extruding step includes indirectly extruding.
Patent AU-1998697-A (AU)
Title: Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
IPC: A61K31/38
Filed: 1997-05-01
Abstract: Compounds of the formula   <IMAGE>   where W is (CH2)n where n is 1 or 2, or n is O and W represents lower alkyl groups attached to each oxygen; m is an integer between 1 and 8; R1 is COOH or a pharmaceutically acceptable salt thereof, COOR4, CONR5R6, CONR5SO2R7, CH2OH, CH2OR7, CH2O-COR7, CH2O-CONR5, R7, CH2OCOOR7, CH2NH2, CH2NR5R6, CH2NR5COR7, CHO, CH(OR8)2, CHOR9O, -COR10, CR10(OR8)2, or CR10OR9O, where R4 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R4 is phenyl or lower alkylphenyl, R5 and R6 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or phenyl or lower alkylphenyl, R7 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R8 is lower alkyl, and R9 is divalent alkyl radical of 2-5 carbons, R10 is an alkyl OR cycloalkyl containing 1 to 5 carbons; R2 is H, COR7, R7, CO-OR7, CO-NR5, R7, PO(OH)OR7, PO(OR7)2, POR7OH, or POR7(OR7); R3 is lower alkyl, phenyl, lower alkyl or halogen substituted phenyl, phenyl substituted lower alkyl, or heteroaryl substituted lower alkyl, are capable of lowering introaocular pressure in the eye of a mammal.
Patent AU-2117588-A (AU)
Title: Process for microencapsulation, uses of polymers prepared by said process, and compositions containing polymers prepared by said process
Inventor: KIELBANIA ANDREW JOHN JR
IPC: B01J13/02
Filed: 1988-08-22
Abstract: A process for encapsulating a wide variety of target materials, including both hydrophilic and hydrophobic materials, employs condensation of two reactive compounds to form shells around core phase drops/particles including target mateial dispersed in a continuous phase. One of the reactive compounds has at least two active methylene functional groups per molecule, the other being an active methylene-reactive crosslinking agent. Either type of the reactive compounds can be dispersed in the continuous phase, the other being dispersible in the core phase. Applications include controlled release mocroencapsulation of agriculture chemicals and biocides.
Patent AU-2315100-A (AU)
Title: Human adult astrocytes, their preparation and uses thereof
Inventor: RIDET JEAN-LUC
IPC: A61K35/12
Filed: 2000-01-05
Abstract: The invention provides an essentially pure preparation of human adult astrocytes, and a method of producing same. The purified astrocytes are useful for the treatment of neurodegenerative disorders or trauma to the central nervous system.
Patent AU-2323897-A (AU)
Title: Cyclopropyl alkanoic acid derivatives
Inventor: CHEN BARBARA B
IPC: C07D239/42
Filed: 1997-03-20
Abstract: The present invention relates to a class of compounds represented by the Formula I   <IMAGE>   or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the  alpha v beta 3 integrin.
Patent AU-2611392-A (AU)
Title: A mechanism for advancing package blanks
IPC: B65B41/10
Filed: 1992-10-01
Abstract: The invention relates to a mechanism for advancing flat-laid package blanks (10) disposed in a magazine (14). A shaft (1) extending through the mechanism at right angles to the magazine (14) is journalled by means of a free-wheel hub (5) so that it may rotate in only one direction. The shaft (1) is urged against at least one endless elastic belt (9) which interconnects two or more wheels (11). In its turn, the belt (9) presses against the flat-laid package, blanks (10). The free-wheel hub (5) is surrounded by a lever (6), reciprocally pivotal and connected to a drive unit (8). When the lever (6) is pivoted in the one direction, the movement is transferred via the shaft (1) to the belt (9) and the package blanks (10) are fed forwardly in the magazine (14). When the lever (6) is pivoted in the other direction, the free-wheel hub (5) locks and no movement is transmitted to the belt (9) which might counteract the forward advancement of the package blanks (10) in the magazine (14). <IMAGE>
Patent AU-2748701-A (AU)
Title: Rapamycin analogs
Inventor: KATZ LEONARD
IPC: C12N1/21
Filed: 2000-10-30
Abstract: Recombinant host cells that produce rapamycin analogues are constructed by deleting or modifying rapamycin biosynthetic gene cluster genes and are useful in the production of compounds used as antifungals, anticancers, immunosuppressants, and neurotrophins.
Patent AU-2870295-A (AU)
Title: Polymerization catalyst systems, their production and use
Inventor: SPECA ANTHONY NICHOLAS
IPC: C08F10/00
Filed: 1995-06-21
Abstract: This invention is generally directed toward a supported catalyst system useful for polymerizing olefins. The method for supporting the catalyst system of the invention provides for a metallocene catalyst and alumoxane activator supported on a porous support using a total volume of catalyst solution that is less than that of which a slurry is formed. The metallocene and alumoxane aer mixed in solution, then the solution is added to a porous support in a volume between the total pore volume of the support and the volume at which a slurry forms. The solvent is then removed, leaving an activated supported metallocene.
Patent AU-3086589-A (AU)
Title: Nickel-chromium-molybdenum alloy
Inventor: HEUBNER ULRICH
IPC: C22C19/05
Filed: 1989-03-02
Abstract: The use of an alloy containing 22.0 to 24.0% of chromium, 15.0 to 16.5% of molybdenum, up to 0.3% of tungsten, up to 1.5% of iron, up to 0.4% of vanadium, 0.1 to 0.4% of aluminium, 0.001 to 0.04% of magnesium and 0.001 to 0.01% of calcium, the remainder being nickel and including unavoidable accompanying elements and impurities, is proposed for the production of structural components which have very good resistance to material-removing corrosion and to pitting corrosion and crevice corrosion under very severe corrosive conditions, as prevail in present-day chemical process engineering and in current environment protection technology, such as, for example, in flue gas desulphurisation plants or plants for concentrating sulphuric acid, and which should be capable of being produced economically and without problems by hot-working and cold-working.
Patent AU-3133589-A (AU)
Title: Bottom-up filler
Inventor: VRIES CORNELIS LEONARDUS DE
IPC: B65B3/32
Filed: 1989-03-15
Abstract: Apparatus for volumetric dosing of viscous products comprising a dispensing outlet (3), means for substantially vertically moving said outlet, a supply conduit (1), a valve for said supply conduit, a dispensing valve (9) and a dosing chamber (10), said dispensing outlet constituting the lower end of the dosing chamber. Preferably the apparatus comprises means for sucking back product to prevent dripping.
Patent AU-3145499-A (AU)
Title: Soap gel based glue stick
Inventor: MAIER WOLFGANG
IPC: C08G18/66
Filed: 1999-03-17
Abstract: Adhesive sticks are obtained using water-based preparations of synthetic polymers of adhesive character and soaps which act as shaping gel-forming components. Mixtures of polyurethanes and polyvinyl pyrrolidone are used as the synthetic polymers. The polyurethane may be in the form of a dispersion and produced by reacting at least one polyol, at least one polyfunctional isocyanate and a component capable of salt formation in alkaline aqueous solution and/or a nonionic hydrophilic modifying agent.
Patent AU-3215101-A (AU)
Title: A protease, a gene therefor and the use thereof
Inventor: PARK HO-YONG
IPC: A23L13/00
Filed: 2000-12-29
Abstract: The present invention relates to a protease, and more specifically to a protease derived from Aranicola proteolyticus, a gene coding for said enzyme, a gene expression system for said protease, a process for purifying the protease, and the uses of said protease in industrial applications, such as for example, detergents, cosmetics, leather processing agents, chemicals for laboratory research, solubilizing or softening agents for food, meat modifier, feed or food additives, or oil and fat separating agents, as well as pharmaceutical compositions.
Patent AU-3344284-A (AU)
Title: Process for the production of dimethyldichlorosilane
Inventor: HOMME CHRISTIAN PRUD
IPC: C07F7/16
Filed: 1984-09-24
Abstract: Dimethyldichlorosilane is directly prepared from methyl chloride and silicon, in high productivity, selectivity and degree of silicon conversion, by reacting methyl chloride with a solid contact mass comprising silicon and a catalytically effective amount of a catalyst which includes (1) elemental copper or a copper compound, (2) from about 30 to 1,000 ppm (calculated as metallic tin and/or antimony) of at least one of the metals tin and antimony, or at least one compound of at least one of the metals tin and antimony, and (3) from about 0.05 to 4% by weight, (calculated as cesium metal) of cesium or a cesium compound, or admixture of cesium with up to 90% by weight of the admixture of lithium, sodium, potassium or rubidium, the amounts of said components (2) and (3) being based upon the total weight of said solid contact mass.
Patent AU-3405101-A (AU)
Title: Enhanced compression of gray-level images
Inventor: ZLOTNICK AVIAD
IPC: H04N1/41
Filed: 2001-02-19
Abstract: A method for compression of an input image that includes a plurality of pixels having respective input pixel values. The method includes quantizing the input pixel values so as to generate respective quantized pixel values, and generating a quantized image by substituting the quantized pixel values for the respective input pixel values in the input image. The input pixel values in the input image are reordered so as to generate a reordered image in which the input pixel values are grouped by their respective quantized values. The quantized image and the reordered image are compressed so as to generate a compressed output image file.
Patent AU-3461697-A (AU)
Title: Heterocyclic compounds, their production and use
Inventor: MOMOSE YU
IPC: C07D521/00
Filed: 1997-07-17
Abstract: Heterocyclic compounds represented by general formula (I): <CHEM>     wherein R stands for an optionally substituted aromatic heterocyclic group; X stands for oxygen atom, an optionally oxidized sulfur atom, -C(=O) or - CH(OH)-;   Y stands for CH or N;   m denotes an integer of 0 to 10;   n denotes an integer of 1 to 5;   the cyclic group: <CHEM> stands for an optionally substituted aromatic azole group; and ring A may be further substituted,  or salts thereof. The compound (I) possesses action of inhibiting tyrosine kinase and is useful as an antitumor agent.
Patent AU-3580800-A (AU)
Title: Method of and compositions for immunization with the (pseudomonas) v antigen
Inventor: FRANK DARA W
IPC: A61K38/00
Filed: 1999-11-23
Abstract: A method of inhibiting, moderating or diagnosing  Pseudomonas aeruginosa  infection is disclosed. In one embodiment, this method comprises inoculating a patient with an effective amount of PcrV antigen.
Patent AU-3668997-A (AU)
Title: Deformylation of f-met peptides in bacterial expression systems
Inventor: BOGOSIAN GREGG
IPC: C07K14/54
Filed: 1997-07-17
Abstract: A method for producing recombinant peptides and proteins having a diminished retention of N-formyl-methionine by coexpressing a peptide deformylase enzyme is disclosed. Also disclosed are substantially deformylated protein compositions and transformed bacterial cells and DNA vectors useful for acheiving such deformylation.
Patent AU-3698399-A (AU)
Title: Rolling stand with crossing back-up and/or working rolls
Inventor: QUAMBUSCH HERBERT
IPC: B21B13/02
Filed: 1999-03-02
Abstract: A roll stand with backup rolls and work rolls for rolling sheet and strip in which the upper and lower work rolls, together with the backup rolls associated therewith, can be displaced from the common vertical plane into positions in which the vertical planes passing through the roll axes of the work rolls and backup rolls intersect in that chocks supporting each roll within the housing window are displaced in pairs horizontally in opposite directions. Each pair of rolls formed of the upper and lower backup rolls and work rolls is received by its roll chocks in one of two cassettes extending horizontally into the housing windows located on either side of the roll housing and is guided therein such that it can be vertically and/or horizontally adjusted. The cassettes can be swiveled in opposite directions about a common central vertical axis formed by upper and lower centering pin bearings provided at the housing crosspiece and at the cassette, and each cassette is vertically supported in the area of the housing windows against the roll stand frame by articulated supports mounted on cardan joints at both ends.
Patent AU-3849089-A (AU)
Title: A method of adjusting the phase of a clock generator with respect to a data signal
Inventor: NORDBY RASMUS
IPC: H04L7/033
Filed: 1989-06-23
Abstract: PCT No. PCT/DK89/00157 Sec. 371 Date Dec. 21, 1990 Sec. 102(e) Date Dec. 21, 1990 PCT Filed Jun. 23, 1989 PCT Pub. No. WO89/12936 PCT Pub. Date Dec. 28, 1989.In a method of adjusting the phase of a clock generator with respect to a data signal (50) an auxiliary signal (52) is generated by comparing the data signal (50) and a clock signal (51). The auxiliary signal (52) exhibits a disuniform representation corresponding to various data bit sequences. The data sequences are detected and combined with the auxiliary signal to generate a phase adjustment signal (54) with a uniform representation corresponding to the various data bit sequences and having an average value depending upon the phase difference between clock signal and data signal. Further, a reference signal (55) may be generated, representing the average value of the phase adjustment signal (54) which responds to ideal phase state. This reference signal (55) in combination with the phase adjustment signal (54) may be used for an even more precise adjustment of the phase of the clock generator with respect to the data signal.
Patent AU-3964800-A (AU)
Title: Novel protective cultures and use thereof for preserving foodstuffs
Inventor: ELSSER DIETER
IPC: A23L13/70
Filed: 2000-04-05
Abstract: Protective cultures for preserving food and animal feed that can be stored for limited periods by chilling comprising non-pathogenic lactic acid bacteria, is new. Protective cultures for preserving food and animal feed that can be stored for limited periods by chilling comprise non-pathogenic lactic acid bacteria, in which: (a) the bacteria have no metabolic activity below 7-8 [deg]C detectable by the senses; (b) the number with potential metabolic activity in 1-2 weeks below 7-8 [deg]C is less than 10 2>; and (c) the bacteria inhibit the growth of toxinogenic and/or toxi-infectious bacteria at not less than 7-8 [deg]C. Independent claims are also included for the following: (1) lactic acid bacteria of the Lactococcus lactis subspecies lactis 1526 (DSM 12145) strain; and (2) food and animal feed containing the protective cultures.
Patent AU-4065602-A (AU)
Title: Medical device with position sensor having accuracy at high temperatures
Inventor: GOVARI ASSAF
IPC: G01B7/004
Filed: 2002-05-15
Abstract: A medical device and position sensor combination for use in medical applications comprises a position sensor having a core made of a high permeable material . The core material is made of a Wiegand effect material comprising a mixture of cobalt, vanadium, and iron. The position sensor has an outer diameter of approximately 0.4mm and is used in a medical device having an outer diameter of approximately 0.67mm. <IMAGE>
Patent AU-4418993-A (AU)
Title: Paper sheet guiding cylinder for a printing machine
Inventor: DETMERS ANDREAS
IPC: B65H29/24
Filed: 1993-06-17
Abstract: A printing machine has side frames and a printing machine drive. A paper sheet guiding cylinder is mounted in the side frames of the printing machine, is drivingly connected to the printing machine drive and has an axis. The paper sheet guiding cylinder includes a cylindrical casing and side walls with through holes formed therein. The paper sheet guiding cylinder has a rotatably mounted radial ventilator being coaxial with the axis of the paper sheet guiding cylinder for supplying blowing air into the paper sheet guiding cylinder and for deflecting the blowing air inside the paper sheet guiding cylinder towards the cylindrical casing. The radial ventilator has end surfaces communicating with the ambient air through the holes and ventilator blades being disposed concentrically about the axis of the paper sheet guiding cylinder and extending along the paper sheet guiding cylinder. A drive for the paper sheet guiding cylinder has adjustable speed and is independent of the paper sheet guiding cylinder.
Patent AU-4457085-A (AU)
Title: Synthesis of hgrf (somatocrinin)
Inventor: DIAZ JOSEPH
IPC: C07K5/00
Filed: 1985-07-04
Abstract: A process for the synthesis, in liquid phase and by fragments, of hGRF 1-44 and hGRF 1-40. This process consists in coupling, one after the other and in the order of the sequence of the GRF, (1) on the one hand, the following fragments: -H-Ala-Arg-Ala-Arg-Leu-NH2 called Fragment A hGRF (40-44) or -   alaninamide (40) -H-Gln-Glu-Arg-Gly-OH called Fragment B'1 hGRF (36-39) -H-Glu-Ser-Asn-OH called Fragment B'2 hGRF (33-35) -H-Ser-Arg-Gln-Gln-Gly-OH called Fragment C hGRF (28-32) -H-Leu-Gln-Asp-Ile-Met-OH called Fragment D' hGRF (23-27) -H-Arg-Lys-Leu-OH called Fragment E'1 hGRF (20-22) -  to obtain the peptide K1 [(hGRF (20-44)] on the corresponding peptide having the sequence (20-40) and (2) on the other hand, the following fragments: -H-Gln-Leu-Ser-Ala called Fragment F1 hGRF (16-19) -H-Tyr-Arg-Lys-Val-Leu-Gly OH called Fragment G1 hGRF (10-15) -H-Ile-Phe-Thr-Asn-Ser-OH called Fragment H1 hGRF (5-9) -  to obtain the peptide J [hGRF (5-19)] and thereafter to couple together the peptides J and K1 in order to form the peptide having the sequence hGRF (5-44) or hGRF (5-40) and finally to couple the resulting peptide with the peptide H-Tyr-Ala-Asp-Ala-OH, called fragment I hGRF (1-4).
Patent AU-4651093-A (AU)
Title: Electromagnetic device and method for boundary layer control
Inventor: NOSENSCHUCK DANIEL M
IPC: F15D1/12
Filed: 1993-06-25
Abstract: The boundary layer of a fluid travelling in a mean-flow direction relative to a surface of a wall of a body is controlled by generating in a near-wall region of the flow a magnetic field  &upbar& B having flux lines parallel to the surface of the wall and an electric current density  &upbar& J traversing the magnetic flux lines in the fluid. An electrolyte or other conductivity-enhancing material is introduced into the flow to provide an electrical conductivity gradient in the near-wall region. The magnetic field  &upbar& B and the electric current density  &upbar& J create in the fluid a force  &upbar& Jx &upbar& B having a component normal to the surface of the wall that because of the increased conductivity gradient near the surface can stabilize or destabilize flow in the boundary layer. Numerous aspects of the fluid flow and its interaction with the body can thus be controlled. As examples, shear stress in the fluid at the wall can be decreased, with a corresponding reduction in viscous drag, the characteristics of the acoustic and pressure fields in the fluid surrounding the body can be controlled to reduce noise and fatigue, and boundary layer separation can be inhibited or induced.
Patent AU-4698193-A (AU)
Title: Electronic lock system
Inventor: THORSEN ANDERS CHRISTIAN
IPC: E05B49/00
Filed: 1993-08-04
Abstract: PCT No. PCT/DK93/00253 Sec. 371 Date Feb. 6, 1995 Sec. 102(e) Date Feb. 6, 1995 PCT Filed Aug. 5, 1992 PCT Pub. No. WO94/03690 PCT Pub. Date Feb. 17, 1994A lock system comprising an electromechanical lock and code generator, and an electronic code lock, which is connected to a code transportation medium. The electronic lock and code generator is a system, where the code medium includes both a mechanical and an electrical code, which both must be present with the correct code before the code transport transmitter can be activated. The transmission of the code takes place within a short time interval and at an individual transmission rate, and a timed blocking is built-in in case of an incorrect optical code, and a circuit counteracting voltage manipulation is built-in. The code transportation medium is electrical or optical. The electronic code lock is a system, where the correct code must be received twice successively. A built-in timed blocking of the analysis of the code is activated if an incorrect code is received, or if the code has not been received at the correct transmission rate, and an electronic circuit counteracting voltage manipulation is built-in.